001     181977
005     20240229145703.0
024 7 _ |a 10.1126/sciadv.abq4469
|2 doi
024 7 _ |a pmid:36197975
|2 pmid
024 7 _ |a altmetric:136836672
|2 altmetric
037 _ _ |a DKFZ-2022-02339
041 _ _ |a English
082 _ _ |a 500
100 1 _ |a Bonadonna, Michael
|b 0
|e First author
245 _ _ |a Iron regulatory protein (IRP)-mediated iron homeostasis is critical for neutrophil development and differentiation in the bone marrow.
260 _ _ |a Washington, DC [u.a.]
|c 2022
|b Assoc.
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1669037205_7316
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a #EA:F170#LA:F170#
520 _ _ |a Iron is mostly devoted to the hemoglobinization of erythrocytes for oxygen transport. However, emerging evidence points to a broader role for the metal in hematopoiesis, including the formation of the immune system. Iron availability in mammalian cells is controlled by iron-regulatory protein 1 (IRP1) and IRP2. We report that global disruption of both IRP1 and IRP2 in adult mice impairs neutrophil development and differentiation in the bone marrow, yielding immature neutrophils with abnormally high glycolytic and autophagic activity, resulting in neutropenia. IRPs promote neutrophil differentiation in a cell intrinsic manner by securing cellular iron supply together with transcriptional control of neutropoiesis to facilitate differentiation to fully mature neutrophils. Unlike neutrophils, monocyte count was not affected by IRP and iron deficiency, suggesting a lineage-specific effect of iron on myeloid output. This study unveils the previously unrecognized importance of IRPs and iron metabolism in the formation of a major branch of the innate immune system.
536 _ _ |a 316 - Infektionen, Entzündung und Krebs (POF4-316)
|0 G:(DE-HGF)POF4-316
|c POF4-316
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
700 1 _ |a Altamura, Sandro
|0 0000-0002-6781-1073
|b 1
700 1 _ |a Tybl, Elisabeth
|0 P:(DE-He78)ea8ac056472f2c0db921980d001d08b3
|b 2
700 1 _ |a Palais, Gael
|0 P:(DE-He78)e4d85ca7303cece48a706a304fc31d79
|b 3
700 1 _ |a Qatato, Maria
|b 4
700 1 _ |a Polycarpou-Schwarz, Maria
|b 5
700 1 _ |a Schneider, Martin
|0 P:(DE-He78)791bcedb383e7bff44eaaf21584be871
|b 6
700 1 _ |a Kalk, Christina
|b 7
700 1 _ |a Rüdiger, Wibke
|0 P:(DE-He78)04844af8e0787bbda58a71aec778f579
|b 8
700 1 _ |a Ertl, Alina
|0 P:(DE-He78)74bde30dbc1c493a07fc0e0a0f8a3354
|b 9
700 1 _ |a Anstee, Natasha
|b 10
700 1 _ |a Bogeska, Ruzhica
|b 11
700 1 _ |a Helm, Dominic
|b 12
700 1 _ |a Milsom, Michael D
|b 13
700 1 _ |a Galy, Bruno
|0 P:(DE-He78)00eb6e35f6edc7e5fcb2aacc7a21f891
|b 14
|e Last author
773 _ _ |a 10.1126/sciadv.abq4469
|g Vol. 8, no. 40, p. eabq4469
|0 PERI:(DE-600)2810933-8
|n 40
|p eabq4469
|t Science advances
|v 8
|y 2022
|x 2375-2548
909 C O |p VDB
|o oai:inrepo02.dkfz.de:181977
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 2
|6 P:(DE-He78)ea8ac056472f2c0db921980d001d08b3
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 3
|6 P:(DE-He78)e4d85ca7303cece48a706a304fc31d79
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 6
|6 P:(DE-He78)791bcedb383e7bff44eaaf21584be871
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 8
|6 P:(DE-He78)04844af8e0787bbda58a71aec778f579
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 9
|6 P:(DE-He78)74bde30dbc1c493a07fc0e0a0f8a3354
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 14
|6 P:(DE-He78)00eb6e35f6edc7e5fcb2aacc7a21f891
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-316
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Infektionen, Entzündung und Krebs
|x 0
914 1 _ |y 2022
915 _ _ |a Creative Commons Attribution-NonCommercial CC BY-NC (No Version)
|0 LIC:(DE-HGF)CCBYNCNV
|2 V:(DE-HGF)
|b DOAJ
|d 2021-01-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2021-01-30
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2021-01-30
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2021-01-30
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2021-01-30
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b SCI ADV : 2021
|d 2022-11-08
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2022-11-08
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2022-11-08
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2021-09-20T13:50:30Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2021-09-20T13:50:30Z
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Blind peer review
|d 2021-09-20T13:50:30Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2022-11-08
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2022-11-08
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2022-11-08
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2022-11-08
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1040
|2 StatID
|b Zoological Record
|d 2022-11-08
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1150
|2 StatID
|b Current Contents - Physical, Chemical and Earth Sciences
|d 2022-11-08
915 _ _ |a IF >= 10
|0 StatID:(DE-HGF)9910
|2 StatID
|b SCI ADV : 2021
|d 2022-11-08
920 2 _ |0 I:(DE-He78)F170-20160331
|k F170
|l F170 Virus-assoziierte Karzinogenese
|x 0
920 1 _ |0 I:(DE-He78)F170-20160331
|k F170
|l F170 Virus-assoziierte Karzinogenese
|x 0
920 1 _ |0 I:(DE-He78)A012-20160331
|k A012
|l A012 Experimentelle Hämatologie
|x 1
920 1 _ |0 I:(DE-He78)W120-20160331
|k W120
|l Proteinanalyse
|x 2
920 0 _ |0 I:(DE-He78)F170-20160331
|k F170
|l F170 Virus-assoziierte Karzinogenese
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)F170-20160331
980 _ _ |a I:(DE-He78)A012-20160331
980 _ _ |a I:(DE-He78)W120-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21